Market Access Consulting

End-to-End Market Access Consulting for Life Sciences, Health Foods, Industrial and Consumer Goods.

At Cisema, we deliver comprehensive market access consulting services tailored to the unique requirements of pharmaceutical, biotech, medical device, veterinary, cosmetic, health food, and industrial goods companies. Our mission is to help you overcome access challenges, unlock coverage decisions, and drive commercial success in China and across Asia Pacific markets.

Market access consulting
Market access strategy

Market Access Consulting for
Pharma & Biotech

Successfully entering the pharmaceutical and biotech markets in Asia Pacific requires more than regulatory approval; it demands a strategic, data-driven approach. Cisema supports your product journey with integrated market access solutions that combine regulatory and clinical strategy, health economics real-world evidence and payers insights. Our goal is to accelerate access, ensure compliance and optimize patient outcomes while aligning with market dynamics and stakeholder expectations.

Regulatory & Access Intelligence

Stay ahead of evolving market dynamics with timely, actionable insights. We continuously monitor Health Technology Assessment (HTA) developments, pricing frameworks, coverage decisions, and policy updates across China and the Asia Pacific region to keep your market access strategy informed and competitive.

Pricing & Reimbursement Strategy

We develop locally tailored pricing strategies grounded in clinical evidence, real world data, and health economics modeling. Our team ensures alignment with payer expectations across systems such as China’s National Reimbursement Drug List (NRDL) and Provincial Reimbursement Drug List (PRDL), and regional listing frameworks.

Health Economics & Outcomes Research (HEOR)

Demonstrate product value through rigorous economic modeling. Our experts develop cost-effectiveness analysis, budget impact models, and comparative studies aligned with local Health Technology Assessment (HTA) requirements to support reimbursement and coverage decisions.

Reimbursement Dossier Preparation

Accelerate market access with comprehensive, high-quality dossiers. We compile clinical trial data, real world outcomes, and local market intelligence to support early engagement with payers and secure listing approvals.

Market Entry & Access Strategy

From direct registration to strategic partnerships and tender submissions, we craft localized access strategies tailored to each market’s procurement and reimbursement landscape maximizing reach and patient access.

Competitor & Market Landscape Analysis

Gain strategic advantage through deep market intelligence. We benchmark competitors, pricing, and access conditions to inform your positioning and differentiate your product in crowded or emerging markets.

Stakeholder Engagement & Value Communication

Our consultants facilitate engagement with national and regional key decision makers including HTA bodies, payers, and Key Opinion Leaders (KOLs) by shaping compelling value narratives to support market access, drive decisions and address unmet needs.

Clinical trial medical device

Market Access Consulting for Medical Devices, IVDs & Veterinary Products

Market access consulting for medical devices, IVDs, and veterinary products includes full regulatory support, strategic planning, and post-approval data generation to drive patient access and commercial success.

Regulatory Approval

We secure registration from national authorities such as the NMPA in China and the HSA in Singapore.

Procurement Listing

We help you gain access through inclusion in public and private procurement systems across Asia Pacific.

Real World Evidence

We assist in post-market data collection and real-world performance tracking to support ongoing coverage and reimbursement.

Commercial Strategy

With our network of regional partners, we design contracting and distribution models that align with healthcare delivery and improve patient outcomes.

Market Access Consulting for Quasi-Drugs, Cosmetics, Ingredients, Health Foods, & Supplements

Our market access consulting services support clients targeting the complex and regulated markets of China, Hong Kong, Taiwan, South Korea, and Southeast Asia. We specialize in market access solutions for quasi-drug products, cosmetics, cosmetic ingredients, health foods, and dietary supplements, providing expert support for all compliance and certification needs.

Regulatory Compliance

We help you meet national requirements for product classification, labeling, safety, and claims. Whether you are registering a cosmetic in Taiwan, a health supplement in China, or a functional food in South Korea, our consultants ensure your product is ready for global market access and regional success.

Testing

We guide you through testing processes required across Asia Pacific to ensure your cosmetic or health food product is compliant, safe, and trusted. With our expert guidance, your products can meet all local standards and access regulated distribution channels while enhancing consumer trust and communicating your product’s value.

Market Access Consulting for Consumer Products & Industrial Goods

Our market access consulting services support clients targeting the complex and regulated markets of China, Hong Kong, Taiwan, South Korea, and Southeast Asia. We specialize in market access solutions for consumer and industrial products, providing expert support for all compliance and certification needs.

Regulatory Compliance

We help you meet national requirements for product classification, labeling, safety, and claims. Whether you are registering fire safety equipment in China, an electronic product in South Korea, or industrial components for export, our consultants ensure your product is ready for global market access and regional success.

Customs & Tariffs

We provide support in managing customs processes, tariffs, and regional trade agreements, helping you measure cost impacts, speed time-to-market, and maintain competitive pricing in global markets.

Certification & Testing

With our expert guidance, your products can meet all local standards and access regulated distribution channels while enhancing consumer trust and communicating your product’s value.

RoHS Compliance
Product Administrative License (PAL)
Network Access License (NAL)
Radio Transmission Equipment Certification (SRRC)
Korea Certification (KC)

With our expert guidance, your products can meet all local standards and access regulated distribution channels while enhancing consumer trust and communicating your product’s value.

Read the Latest Regulatory News

View More

China GACC Revises Filing Rules for Imported Food Importers & Exporters

GACC has simplified filing for imported-food importers and exporters while strengthening port verification, change reporting and ongoing supervision.

November 18, 2026
China GACC Revises Filing Rules for Imported Food Importers & Exporters

Beijing MPA Clarifies Electronic Customs Clearance Pilot for Imported Drugs

Beijing's pilot allows companies to download and print approved import clearance documents digitally, reducing paperwork while maintaining existing regulatory requirements.

November 18, 2026
Beijing MPA Clarifies Electronic Customs Clearance Pilot for Imported Drugs

China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices

China has introduced GMP inspection guidelines for sterile, implantable, IVD, custom-made denture and standalone software medical devices.

November 16, 2026
China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices
Two Chinese laboratory professionals check a benchtop blood analyzer as one loads a rack of capped sample tubes.

India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated

India’s CDSCO releases final medical device software guidance under MDR 2017, outlining licensing routes, software risk classes, and cybersecurity standards.

November 16, 2026
India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated
Two Indian clinicians review a chest X-ray on a tablet, where diagnostic software has flagged an area in one lung.

Singapore Updates GN-15 Medical Device Registration Guidance

Singapore’s HSA has revised GN-15 medical device registration guidance, updating submission templates, SaMD requirements and post-market expectations.

November 12, 2026
Singapore Updates GN-15 Medical Device Registration Guidance

China MARA Releases 7th Edition Veterinary Pharmacopoeia Volume III

Find out which imported veterinary biological products need updated testing, revised registration standards, or regulatory approval before May 2027.

November 3, 2026
China MARA Releases 7th Edition Veterinary Pharmacopoeia Volume III
Previous
Previous

Get in Touch with Our China Experts

Speak with our specialists to explore how our access consulting, regulatory services, and operational support can help your company succeed in the region’s evolving market access landscape.

Talk to an Expert